Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
A 2025 paper published in BioImpacts confirmed topical GHK is increasingly being studied as a clinical anti-aging compound with hair restoration applications and that injectable forms are now entering clinical interest following the FDA's April 2026 decision to remove GHK-Cu from the Category 2 restricted list
STAT3 inhibition of gluconeogenesis is downregulated by SirT1
Additionally, many other conditions can be treated with Glutathione, including myocardial infarction, diabetes, Parkinson's disease, Alzheimer's, HIV, and brain injuries from trauma
Extending the treatment times revealed the same species, indicating that GSO 3 H is the final and the only oxidation product
This is why working with a medical professional who understands your health history is so important for any regenerative medicine treatment
Perfectly measurable
